Illumina Inc (ILMN)

Jan 14, 2025, 2:21 PM EST - 3 days ago

Illumina, Inc. (ILMN) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

Jan 14, 2025, 9:00 AM EST - 3 days ago

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025

Jan 13, 2025, 9:01 AM EST - 4 days ago

Illumina and NVIDIA collaborate to decode biology and propel precision health

Jan 13, 2025, 6:07 AM EST - 4 days ago

Truveta sells stakes to Regeneron, Illumina in deal to build genetic database

REGN

Jan 13, 2025, 3:01 AM EST - 4 days ago

Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples

Jan 9, 2025, 4:22 PM EST - 8 days ago

Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025

Jan 7, 2025, 9:15 AM EST - 10 days ago

Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications

Dec 17, 2024, 9:13 AM EST - 4 weeks ago

Ovation.io and Illumina Collaborate to Advance Genomic Data Research

Dec 5, 2024, 7:00 AM EST - 6 weeks ago

11 Ultra SWAN Bargains That Could Thrive As The Market Soars To Record Highs

ADBE AMZN BXP CMCSA DXCM GPN PFE

Dec 4, 2024, 4:07 PM EST - 6 weeks ago

Illumina To Webcast Upcoming Investor Conference

Dec 4, 2024, 3:30 AM EST - 6 weeks ago

Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications

Dec 3, 2024, 4:41 PM EST - 6 weeks ago

Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)

Nov 20, 2024, 2:09 PM EST - 2 months ago

Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Wolfe Research 2024 Healthcare Conference (Transcript)

Nov 19, 2024, 9:15 AM EST - 2 months ago

Illumina announces expansion of TruSight Oncology portfolio

Nov 6, 2024, 4:05 PM EST - 2 months ago

Illumina To Webcast Upcoming Investor Conferences

Nov 5, 2024, 1:12 PM EST - 2 months ago

Illumina: Q3 Confirms Improving Fundamentals

Nov 4, 2024, 8:09 PM EST - 2 months ago

Illumina, Inc. (ILMN) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 2 months ago

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024

Oct 31, 2024, 9:15 AM EDT - 2 months ago

Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting

Oct 9, 2024, 12:10 PM EDT - 3 months ago

Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers

Oct 9, 2024, 12:05 PM EDT - 3 months ago

Illumina launches compact, low-cost gene sequencing devices

Oct 7, 2024, 4:05 PM EDT - 3 months ago

Illumina to Announce Third Quarter 2024 Financial Results on Monday, November 4, 2024

Oct 7, 2024, 12:36 AM EDT - 3 months ago

Revisiting Illumina

Oct 3, 2024, 5:46 PM EDT - 3 months ago

Charles Dadswell to step down as General Counsel, Illumina initiates search for successor

Oct 2, 2024, 12:08 PM EDT - 3 months ago

Illumina Inc (ILMN) Trading 5.9% Higher on Oct 2

Sep 24, 2024, 12:41 PM EDT - 4 months ago

GRAIL: Post-Spinoff, Illumina Maintains Control And Incentive To Support Success

GRAL

Sep 9, 2024, 9:09 AM EDT - 4 months ago

FDA Approves Illumina's TruSight Oncology Comprehensive Assay, Now Offered by PreCheck Health Services as "SolidTumorCheck+" -- A Breakthrough in Precision Oncology

Sep 3, 2024, 3:59 AM EDT - 4 months ago

European Court of Justice rules in favor of Illumina in jurisdictional appeal

Sep 3, 2024, 3:50 AM EDT - 4 months ago

EU top court backs Illumina fight against EU probe into Grail deal

GRAL

Aug 29, 2024, 4:16 PM EDT - 5 months ago

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology

GRAL

Aug 27, 2024, 9:15 AM EDT - 5 months ago

FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies

Aug 20, 2024, 10:34 PM EDT - 5 months ago

Illumina Sees The Light: GRAIL Is Gone, Focus Restored (Rating Upgrade)

Aug 18, 2024, 12:25 PM EDT - 5 months ago

Illumina Looks Bullish (Technical Analysis)

Aug 13, 2024, 7:49 PM EDT - 5 months ago

Illumina, Inc. (ILMN) Illumina 2024 Strategy Update Special Call

Aug 13, 2024, 1:10 PM EDT - 5 months ago

Illumina, CRISPR-pioneer Broad Institute to work on new gene sequencing kits

Aug 13, 2024, 11:00 AM EDT - 5 months ago

Illumina announces strategy to accelerate value creation

Aug 6, 2024, 9:32 PM EDT - 5 months ago

Illumina, Inc. (ILMN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 6:54 PM EDT - 5 months ago

Illumina expects full-year sales from core segment to decline on biotech funding crunch

Aug 6, 2024, 4:05 PM EDT - 5 months ago

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2024

Aug 5, 2024, 9:15 AM EDT - 5 months ago

Illumina launches new oncology menu for NovaSeq X Series customers

Jul 18, 2024, 4:05 PM EDT - 6 months ago

Illumina to Present Upcoming Strategy Update

Jul 18, 2024, 9:00 AM EDT - 6 months ago

Illumina Ventures Adds Two New Experts as Advisors

Jul 12, 2024, 7:00 AM EDT - 6 months ago

What's Happening With Illumina Stock?

Jul 11, 2024, 4:05 PM EDT - 6 months ago

Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024

Jul 10, 2024, 1:05 PM EDT - 6 months ago

Illumina Buys Fluent BioSciences To Gain Stronger Foothold In Single-Cell Analysis

Jul 9, 2024, 4:05 PM EDT - 6 months ago

Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base

Jun 28, 2024, 11:56 AM EDT - 7 months ago

Illumina Takes a $1.47 Billion Charge Related to Its Spinoff of GRAIL

Jun 28, 2024, 4:35 AM EDT - 7 months ago

Illumina: Marriage Made In Hell Is (Finally) Over - Assessing Impact Of GRAIL Spin-Out

GRAL

Jun 27, 2024, 5:26 PM EDT - 7 months ago

Illumina to take $1.47 bln goodwill impairment charge related to Grail in Q2

GRAL